article

Drug Target Review – Issue #2 2015

Posted: 10 June 2015 | Drug Target Review

Included in this issue: Drug Discovery, Screening, Hit-to-Lead, Antibodies, Stem Cells, Kinases and much more…

DTR Issue 2 2015

In Issue #2 2015 of Drug Target Review:

  • FOREWORD: Academic drug discovery in neurodegeneration: a new approach to an ageing problem
    Dr Eric Karran, Director of Research, Alzheimer’s Research UK
  • DRUG DISCOVERY: A new dawn in academic and pharma collaboration – a UK perspective
    Justin Bryans, MRC Technology’s Centre for Therapeutics Discovery
  • IN-DEPTH FOCUS: SCREENING
    Featuring articles from Kenji Schorpp and Kamyar Hadian, Institute of Molecular Toxicology and Pharmacology, Sheraz Gul, Fraunhofer-IME SP and Horst Flotow, Singapore Screening Centre. Plus, Thermo Fisher Scientific’s Market and Product Line Manager Tarja Hirvensalo discusses screening and imaging solutions
  • HIT-TO-LEAD: From hype to hope: challenging the norm in lead discovery
    Andy Merritt, MRC Technology Centre for Therapeutics Discovery
  • ANTIBODIES: Developing antibody therapeutics
    David Matthews, MRC Technology
  • IN-DEPTH FOCUS: STEM CELLS
    With articles from Dennis Schade, Technical University of Dortmund, Arne Hansen, University Medical Center Hamburg-Eppendorf and DZHK, Boris Greber, Max Planck Institute for Molecular Biomedicine, and Ginika J. Jideofor and Jeff D. Newman, Cranfield Institute of Health
  • KINASES: Novel approaches to targeting protein tyrosine kinases
    Danielle McCullough and Dr Carol Trim, Canterbury Christ Church University

Issue #2 2015 is restricted - login or subscribe free to access

Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Related topics

Send this to a friend